This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Biosimilars Naming and Labeling: an FDLI Dialogue

November 16, 2011 , Food and Drug Law Institute, Washington, DC

Share this article: